{"id":"https://openalex.org/W2140909652","doi":"https://doi.org/10.1345/aph.1p268","title":"The Role of Benzalkonium Chloride in the Occurrence of Punctate Keratitis: A Meta-Analysis of Randomized, Controlled Clinical Trials","display_name":"The Role of Benzalkonium Chloride in the Occurrence of Punctate Keratitis: A Meta-Analysis of Randomized, Controlled Clinical Trials","publication_year":2010,"publication_date":"2010-11-30","ids":{"openalex":"https://openalex.org/W2140909652","doi":"https://doi.org/10.1345/aph.1p268","mag":"2140909652","pmid":"https://pubmed.ncbi.nlm.nih.gov/21119099"},"language":"en","primary_location":{"id":"doi:10.1345/aph.1p268","doi":"https://doi.org/10.1345/aph.1p268","is_oa":false,"landing_page_url":"https://doi.org/10.1345/aph.1p268","pdf_url":null,"source":{"id":"https://openalex.org/S113426163","display_name":"Annals of Pharmacotherapy","issn_l":"0012-6578","issn":["0012-6578","1060-0280","1542-6270"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Pharmacotherapy","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071163945","display_name":"Stefan D. Trocm\u00e9","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799343972","display_name":"University Hospitals of Cleveland","ror":"https://ror.org/0130jk839","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972"]},{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Stefan Trocme","raw_affiliation_strings":["Refractive Surgery, Department of Ophthalmology and Visual Sciences, Case Western Reserve University and University Hospitals Eye Institute, Cleveland, OH","Ocular Surface Center and Refractive Surgery, Department of Ophthalmology and Visual Sciences, Case Western Reserve University and University Hospitals Eye Institute, Cleveland, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Refractive Surgery, Department of Ophthalmology and Visual Sciences, Case Western Reserve University and University Hospitals Eye Institute, Cleveland, OH","institution_ids":["https://openalex.org/I58956616"]},{"raw_affiliation_string":"Ocular Surface Center and Refractive Surgery, Department of Ophthalmology and Visual Sciences, Case Western Reserve University and University Hospitals Eye Institute, Cleveland, OH, USA","institution_ids":["https://openalex.org/I2799343972","https://openalex.org/I58956616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110189532","display_name":"Lie\u2010Ju Hwang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lie-Ju Hwang","raw_affiliation_strings":["Ophthalmology, Pfizer Inc., New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ophthalmology, Pfizer Inc., New York, New York","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029513919","display_name":"Gerald W. Bean","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gerald W Bean","raw_affiliation_strings":["Burkett, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Burkett, TX","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030200580","display_name":"Maria Sultan","orcid":"https://orcid.org/0009-0001-3544-0378","observed_orcids":["https://orcid.org/0009-0001-3544-0378"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maria B Sultan","raw_affiliation_strings":["Global Clinical Lead, Pfizer Ophthalmics, Global Medical Organization, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Clinical Lead, Pfizer Ophthalmics, Global Medical Organization, New York, NY","institution_ids":["https://openalex.org/I180857899"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5071163945"],"corresponding_institution_ids":["https://openalex.org/I2799343972","https://openalex.org/I58956616"],"apc_list":{"value":4400,"currency":"USD","value_usd":4400},"apc_paid":null,"fwci":0.3927,"has_fulltext":false,"cited_by_count":20,"citation_normalized_percentile":{"value":0.30105634,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"44","issue":"12","first_page":"1914","last_page":"1921"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","score":0.7807999849319458,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","score":0.7807999849319458,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11826","display_name":"Ocular Infections and Treatments","score":0.1054999977350235,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10997","display_name":"Ocular Surface and Contact Lens","score":0.08089999854564667,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/benzalkonium-chloride","display_name":"benzalkonium chloride","score":0.9990000128746033},{"id":"https://openalex.org/keywords/superficial-punctate-keratitis","display_name":"superficial punctate keratitis","score":0.9909999966621399},{"id":"https://openalex.org/keywords/corneal-toxicity","display_name":"corneal toxicity","score":0.8579999804496765},{"id":"https://openalex.org/keywords/latanoprost","display_name":"latanoprost","score":0.8320000171661377},{"id":"https://openalex.org/keywords/timolol","display_name":"timolol","score":0.9990000128746033},{"id":"https://openalex.org/keywords/glaucoma","display_name":"glaucoma","score":0.7670000195503235},{"id":"https://openalex.org/keywords/ocular-hypertension","display_name":"ocular hypertension","score":1.0},{"id":"https://openalex.org/keywords/ophthalmic-preservatives","display_name":"ophthalmic preservatives","score":0.8140000104904175},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.4790000021457672},{"id":"https://openalex.org/keywords/topical-ophthalmic-solution","display_name":"topical ophthalmic solution","score":0.640999972820282}],"concepts":[{"id":"https://openalex.org/C2776740260","wikidata":"https://www.wikidata.org/wiki/Q634959","display_name":"Latanoprost","level":3,"score":0.9809577465057373},{"id":"https://openalex.org/C2778073030","wikidata":"https://www.wikidata.org/wiki/Q413994","display_name":"Timolol","level":3,"score":0.9255278706550598},{"id":"https://openalex.org/C2775919038","wikidata":"https://www.wikidata.org/wiki/Q108126784","display_name":"Benzalkonium chloride","level":2,"score":0.8949733972549438},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8431594371795654},{"id":"https://openalex.org/C2776521421","wikidata":"https://www.wikidata.org/wiki/Q9294051","display_name":"Ocular hypertension","level":3,"score":0.5896422863006592},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.5585278272628784},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.5542381405830383},{"id":"https://openalex.org/C2778560704","wikidata":"https://www.wikidata.org/wiki/Q757838","display_name":"Keratitis","level":2,"score":0.5138223767280579},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.47827160358428955},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4575875997543335},{"id":"https://openalex.org/C2778527774","wikidata":"https://www.wikidata.org/wiki/Q159701","display_name":"Glaucoma","level":2,"score":0.41150087118148804},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.252981960773468},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.09464305639266968},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000077338","descriptor_name":"Latanoprost","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001548","descriptor_name":"Benzalkonium Compounds","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007634","descriptor_name":"Keratitis","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D007634","descriptor_name":"Keratitis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009883","descriptor_name":"Ophthalmic Solutions","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D011310","descriptor_name":"Preservatives, Pharmaceutical","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D011461","descriptor_name":"Prostaglandins F, Synthetic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011461","descriptor_name":"Prostaglandins F, Synthetic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013999","descriptor_name":"Timolol","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013999","descriptor_name":"Timolol","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1345/aph.1p268","doi":"https://doi.org/10.1345/aph.1p268","is_oa":false,"landing_page_url":"https://doi.org/10.1345/aph.1p268","pdf_url":null,"source":{"id":"https://openalex.org/S113426163","display_name":"Annals of Pharmacotherapy","issn_l":"0012-6578","issn":["0012-6578","1060-0280","1542-6270"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Pharmacotherapy","raw_type":"journal-article"},{"id":"pmid:21119099","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21119099","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Annals of pharmacotherapy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"},{"display_name":"Meta-Analysis","id":"https://openalex.org/study-designs/meta-analysis"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W93725138","https://openalex.org/W185887293","https://openalex.org/W187965746","https://openalex.org/W970378722","https://openalex.org/W1490909919","https://openalex.org/W1572518507","https://openalex.org/W1967951026","https://openalex.org/W1971636582","https://openalex.org/W1978986531","https://openalex.org/W1981684730","https://openalex.org/W1985992536","https://openalex.org/W1988235030","https://openalex.org/W1996539435","https://openalex.org/W2016323750","https://openalex.org/W2022356107","https://openalex.org/W2022879923","https://openalex.org/W2025742823","https://openalex.org/W2037412365","https://openalex.org/W2038961037","https://openalex.org/W2040322156","https://openalex.org/W2043159526","https://openalex.org/W2058122061","https://openalex.org/W2062882436","https://openalex.org/W2064249983","https://openalex.org/W2066340318","https://openalex.org/W2073771651","https://openalex.org/W2076260416","https://openalex.org/W2081599752","https://openalex.org/W2108069709","https://openalex.org/W2123071652","https://openalex.org/W2462871307","https://openalex.org/W2615609614","https://openalex.org/W4240626528"],"related_works":["https://openalex.org/W2346143668","https://openalex.org/W3202625386","https://openalex.org/W2515692276","https://openalex.org/W7095126795","https://openalex.org/W2021117142","https://openalex.org/W1965390284","https://openalex.org/W2383719445","https://openalex.org/W1968092649","https://openalex.org/W2947347349","https://openalex.org/W4205695974"],"abstract_inverted_index":{"BACKGROUND:":[0],"Benzalkonium":[1],"chloride":[2],"(BAK),":[3],"the":[4,31,45,83,93,110,117,123,127,151,174,179,183,193,236,266,277],"most":[5],"commonly":[6],"used":[7,125,149,279],"preservative":[8],"in":[9,17,23,26,58,72,116,126,178,204,210,265,280],"topical":[10],"ophthalmic":[11,64,70],"solutions,":[12],"has":[13,34],"undergone":[14],"considerable":[15],"criticism":[16],"recent":[18],"years,":[19],"principally":[20],"based":[21],"on":[22],"vitro":[24],"and":[25,66,155,209,235],"vivo":[27],"studies.":[28,282],"Relevance":[29],"to":[30,101,167,230,248],"clinical":[32,90],"setting":[33],"not":[35,156,260],"been":[36],"confirmed.":[37],"OBJECTIVE:":[38],"To":[39],"determine":[40],"whether":[41],"administration":[42],"of":[43,47,55,82,86,95,112,132,182,196,221,239,269],"twice":[44,122],"amount":[46,111,124],"BAK":[48,113,258],"was":[49,120,148,153,199,207,213,225,243],"associated":[50],"with":[51,68,74,103,271],"an":[52,140],"increased":[53],"incidence":[54,94,195,203],"punctate":[56,96,133,197,219],"keratitis":[57,97,134,198,220],"long-term,":[59],"double-masked":[60,84,180],"trials":[61,91,184],"comparing":[62],"latanoprost":[63,104,118,222,240],"solution":[65,71],"vehicle":[67],"timolol":[69,128,224,242],"patients":[73,99,176,206,212,270],"glaucoma":[75,272],"or":[76,105,139,273],"ocular":[77,274],"hypertension.":[78],"METHODS:":[79],"A":[80,145],"meta-analysis":[81],"phases":[85],"7":[87],"prospective,":[88],"controlled":[89],"compared":[92],"among":[98],"assigned":[100],"treatment":[102],"timolol.":[106],"In":[107],"all":[108],"studies,":[109],"administered":[114],"daily":[115],"arms":[119],"approximately":[121],"arms.":[129],"All":[130],"reports":[131],"either":[135],"as":[136],"a":[137],"finding":[138],"adverse":[141],"event":[142],"were":[143,161,165],"included.":[144],"fixed-effect":[146],"model":[147],"because":[150],"heterogeneity":[152],"small":[154],"statistically":[157],"significant.":[158],"Sensitivity":[159],"analyses":[160],"conducted.":[162],"Funnel":[163],"plots":[164],"provided":[166],"address":[168],"potential":[169],"publication":[170],"bias.":[171],"RESULTS:":[172],"Of":[173],"1694":[175],"enrolled":[177],"portion":[181],"(latanoprost,":[185],"n":[186,190],"=":[187,191,233,251],"892;":[188],"timolol,":[189],"802),":[192],"overall":[194],"6.3%":[200],"(106/1694).":[201],"The":[202,215],"latanoprost-treated":[205],"6.5%":[208],"timolol-treated":[211],"6.0%.":[214],"risk":[216,237],"difference":[217],"for":[218],"versus":[223,241],"0.005":[226],"(95%":[227,245],"CI":[228,246],"-0.011":[229],"0.020;":[231],"p":[232,250],"0.574),":[234],"ratio":[238],"1.084":[244],"0.739":[247],"1.589;":[249],"0.680).":[252],"CONCLUSIONS:":[253],"These":[254],"results":[255],"indicate":[256],"that":[257],"does":[259],"produce":[261],"significant":[262],"corneal":[263],"toxicity":[264],"vast":[267],"majority":[268],"hypertension":[275],"at":[276],"concentrations":[278],"these":[281]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}